United Therapeutics Corporation (FRA:UTH)

United Therapeutics Revenue

United Therapeutics had revenue of $799.50M USD in the quarter ending September 30, 2025, with 6.76% growth. This brings the company's revenue in the last twelve months to $3.13B, up 13.50% year-over-year. In the year 2024, United Therapeutics had annual revenue of $2.88B with 23.63% growth.

• Revenue (ttm): $3.13B
• Revenue Growth: +13.50%
• P/S Ratio: 6.79
• Revenue / Employee: $2.40M
• Employees: 1,305
• Market Cap: 18.11B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.88B	549.90M	23.63%
Dec 31, 2023	2.33B	391.20M	20.20%
Dec 31, 2022	1.94B	250.80M	14.88%
Dec 31, 2021	1.69B	202.20M	13.63%
Dec 31, 2020	1.48B	34.50M	2.38%